申请人:Boehringer Ingelheim GmbH
公开号:US04026891A1
公开(公告)日:1977-05-31
Compounds of the formula ##STR1## wherein R.sub.1 is hydrogen, trifluoromethyl, alkyl of 1 to 5 carbon atoms, mercapto, lower alkyl-mercapto, phenyl, fluoro-phenyl, tolyl, hydroxy-phenyl, methylmercapto-phenyl, methylsulfinyl-phenyl, methylsulfonyl-phenyl, dimethylamino-phenyl, or mono-, di- or tri-methoxy-substituted phenyl; A is hydrogen or, together with B, a double bond, B is hydrogen, alkyl of 1 to 3 carbon atoms or, together with A, a double bond; C is, together with R.sub.2, a double bond, or, together with R.sub.3, oxygen; R.sub.2 is hydrogen, alkyl of 1 to 3 carbon atoms or, together with C, a double bond; and R.sub.3 is chlorine, methylamino, morpholino, 4-methylpiperazino or, when R.sub.2 is hydrogen or alkyl of 1 to 3 carbon atoms, together with C, oxygen; And non-toxic, pharmacologically acceptable acid addition salts thereof; the compounds as well as the salts are useful as hypotensives, antithrombotics and cardiotonics.
式为##STR1##的化合物,其中R.sub.1为氢、三氟甲基、1至5个碳原子的烷基、巯基、较低烷基巯基、苯基、氟苯基、甲苯基、羟基苯基、甲硫醇基苯基、甲基亚硫醇基苯基、甲基砜基苯基、二甲胺基苯基,或者单、双或三个甲氧基取代的苯基;A为氢或者与B一起形成双键,B为氢、1至3个碳原子的烷基或者与A一起形成双键;C为与R.sub.2一起形成双键,或者与R.sub.3一起形成氧键;R.sub.2为氢、1至3个碳原子的烷基或者与C一起形成双键;R.sub.3为氯、甲氨基、吗啉基、4-甲基哌嗪基,或者当R.sub.2为氢或者1至3个碳原子的烷基时,与C一起形成氧键;以及其非毒性、药理学上可接受的酸盐;这些化合物以及盐可用作降压药、抗血栓药和心脏强心剂。